Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients (2006)
- Authors:
- USP affiliated authors: WAJCHENBERG, BERNARDO LEO - FM ; FUKUI, ROSA TSUNECHIRO - FM ; ROCHA, DALVA MARREIRO - FM
- Unidade: FM
- Subjects: GLICEMIA (CONTROLE;TERAPIA); INFLAMAÇÃO; DIABETES MELLITUS; RESUMOS (CONGRESSOS)
- Language: Inglês
- Imprenta:
- Source:
- Título: Resumos
- Conference titles: ENDO 06 - Annual Meeting the endocrine society's
-
ABNT
TOSTES, Glauce C. U. et al. Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients. 2006, Anais.. Boston: Faculdade de Medicina, Universidade de São Paulo, 2006. . Acesso em: 04 out. 2024. -
APA
Tostes, G. C. U., Silva, M. E. R., Fukui, R. T., Rocha, D. M., & Wajchenberg, B. L. (2006). Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients. In Resumos. Boston: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Tostes GCU, Silva MER, Fukui RT, Rocha DM, Wajchenberg BL. Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients. Resumos. 2006 ;[citado 2024 out. 04 ] -
Vancouver
Tostes GCU, Silva MER, Fukui RT, Rocha DM, Wajchenberg BL. Efficacy of nateglinide or rosiglitazone therapy on glycemic control and serum inflammatory markers in type 2 diabetes patients. Resumos. 2006 ;[citado 2024 out. 04 ] - Differential regulation of PGC-1α expression in rat liver and skeletal muscle in response to voluntary running
- Effects of estrogen theraphy, glimepiride or metformin onfibrinolysis and metabolic profile in peri and postmenopausal women with type 2 diabetes
- Estrogênios conjugados equinos melhoram a complacência vascular em mulheres diabéticas menopausadas
- Efeitos metabólicos e na reatividade vascular de glimepiride e metformina em pacientes com diabetes tipo 2.
- Insulin (IAA), glutamic acid decarboxylase-65 (antigad) and tyrosine-phosphatase (anti-IA2) autoantibodies: prevalence and association with hla-dr haplotypes, ins vntr, and ctla4 in siblings of patients with type 1 diabetes in Brazil
- Sitagliptin versus bedtime NPH insulin as thirdline anti-hyperglycemic agent in type 2 Diabetes Melittus (DM2) treatment
- Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study
- Auto-anticorpos não pancreáticos: prevalencia e associação com HLA-DR/DQ, alelos de classe I do VNTR e CTLA4 em diabetes tipo 1A em pacientes brasileiros
- Efeitos benéficos da associação de rosiglitazona ou metformina à glibenclamida no controle Glicêmico e risco cardiovascular
- Genetic Association of the Lymphoid Tyrosine Phosphatase Locus (LYP/PTPN22) and Type 1 Diabetes in Brazil
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
